Financial Derivatives During the COVID-19 Health Crisis

5 Pages Posted: 14 Jun 2021

See all articles by Mazin A. M. Al Janabi

Mazin A. M. Al Janabi

EGADE Business School, Tecnologico de Monterrey; EGADE Business School, Tecnologico de Monterrey; Economic Research Forum (ERF)

Date Written: June 2, 2021

Abstract

La versión española de este artículo se puede encontrar en: http://ssrn.com/abstract=3858999

During the last years, there has been an increase in the use of derivative instruments, in addition to significant losses reported by companies and financial institutions, putting the appropriate use of this type of product in the spotlight. These instruments supposedly reduce financial risks, but, paradoxically, they are accused of producing new risks. However, are the derivatives themselves or their misuse to blame for these losses? As such, a greater understanding of derivative products and their implicit risks in market disruption events is urgently required.

Keywords: Emerging Markets, Derivative Products, Risk Management, COVID-19, COVID-19 Pandemic

JEL Classification: C10, C13, G20, G28

Suggested Citation

Al Janabi, Mazin A. M., Financial Derivatives During the COVID-19 Health Crisis (June 2, 2021). Available at SSRN: https://ssrn.com/abstract=3858991 or http://dx.doi.org/10.2139/ssrn.3858991

Mazin A. M. Al Janabi (Contact Author)

EGADE Business School, Tecnologico de Monterrey ( email )

Av. Carlos Lazo 100 Col. Santa Fe, Del. Alvaro Obr
Mexico City, 01389
Mexico

EGADE Business School, Tecnologico de Monterrey ( email )

Av. Eugenio Garza Sada #2501
Col. Tecnológico
Monterrey, Nuevo León 64849
Mexico

Economic Research Forum (ERF) ( email )

21 Al-Sad Al-Aaly St.
(P.O. Box: 12311)
Dokki, Cairo
Egypt

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
169
Abstract Views
655
Rank
265,362
PlumX Metrics